Functional alterations of myeloid cells during the course of Alzheimer’s disease
Open Access
- 13 November 2018
- journal article
- research article
- Published by Springer Nature in Molecular Neurodegeneration
- Vol. 13 (1) , 1-11
Abstract
Neuroinflammation is a hallmark of neurodegenerative disease and a significant component of the pathology of Alzheimer’s disease (AD). Patients present with extensive microgliosis along with elevated pro-inflammatory signaling in the central nervous system and periphery. However, the role of peripheral myeloid cells in mediating and influencing AD pathogenesis remains unresolved. Peripheral myeloid cells were isolated from peripheral blood of patients with prodromal AD (n = 44), mild AD dementia (n = 25), moderate/severe AD dementia (n = 28), and age-matched controls (n = 54). Patients were evaluated in the clinic for AD severity and categorized using Clinical Dementia Rating (CDR) scale resulting in separation of patients into prodromal AD (CDR0.5) and advancing forms of AD dementia (mild-CDR1 and moderate/severe-CDR2/3). Separation of peripheral myeloid cells into mature monocytes or immature MDSCs permitted the delineation of population changes from flow cytometric analysis, RNA phenotype analysis, and functional studies using T cell suppression assays and monocyte suppression assays. During stages of AD dementia (CDR1 and 2/3) peripheral myeloid cells increase their pro-inflammatory gene expression while at early stages of disease (prodromal AD—CDR0.5) pro-inflammatory gene expression is decreased. MDSCs are increased in prodromal AD compared with controls (16.81% vs 9.53%) and have markedly increased suppressive functions: 42.4% suppression of activated monocyte-produced IL-6 and 78.16% suppression of T cell proliferation. In AD dementia, MDSC populations are reduced with decreased suppression of monocyte IL-6 (5.22%) and T cell proliferation (37.61%); the reduced suppression coincides with increased pro-inflammatory signaling in AD dementia monocytes. Peripheral monocyte gene expression is pro-inflammatory throughout the course of AD, except at the earliest, prodromal stages when pro-inflammatory gene expression is suppressed. This monocyte biphasic response is associated with increased numbers and suppressive functions of MDSCs during the early stages and decreased numbers and suppressive functions in later stages of disease. Prolonging the early protective suppression and reversing the later loss of suppressive activity may offer a novel therapeutic strategy.Keywords
Funding Information
- Ting Tsung and Wei Fong Chao Foundation in Houston, TX
This publication has 77 references indexed in Scilit:
- Microglia and macrophages of the central nervous system: the contribution of microglia priming and systemic inflammation to chronic neurodegenerationSeminars in Immunopathology, 2013
- Robust and Highly-Efficient Differentiation of Functional Monocytic Cells from Human Pluripotent Stem Cells under Serum- and Feeder Cell-Free ConditionsPLOS ONE, 2013
- Microglia and monocyte-derived macrophages: functionally distinct populations that act in concert in CNS plasticity and repairFrontiers in Cellular Neuroscience, 2013
- Origin and differentiation of microgliaFrontiers in Cellular Neuroscience, 2013
- Inflammation in Alzheimer Disease--A Brief Review of the Basic Science and Clinical LiteratureCold Spring Harbor Perspectives in Medicine, 2011
- Diverse Inflammatory Responses in Transgenic Mouse Models of Alzheimer’s Disease and the Effect of Immunotherapy on These ResponsesASN Neuro, 2011
- Myeloid derived suppressor cells in human diseasesInternational Immunopharmacology, 2011
- The biology of myeloid‐derived suppressor cells: The blessing and the curse of morphological and functional heterogeneityEuropean Journal of Immunology, 2010
- CNS Infiltration of Peripheral Immune Cells: D-Day for Neurodegenerative Disease?Journal of Neuroimmune Pharmacology, 2009
- Regulation of immune responses by L-arginine metabolismNature Reviews Immunology, 2005